Archives

by in
Entry Author Date Location
West Coast Biotech Roundup: Halozyme, Nektar, Allozyne, Novo & More 09/18/14 Seattle
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
Social Media & Cancer Drugs: Conversation, not Promotion 01/23/14 Wisconsin
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
UW Spinoff Resolve Therapeutics Snags $5.8M for Lupus Drug 11/01/12 Seattle
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
MedImmune Cuts 200 Jobs in Bay Area, Keeping Hayward R&D Site 07/16/12 San Francisco
Mymetics Ropes in Dendreon, KPCB Vets to Restart Vaccine Developer 04/11/12 San Francisco
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom 10/05/11 New York
Veterans of J&J, Pfizer, and Medimmune Seek to Transform Arno into Oncology Powerhouse 07/19/11 New York
Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A 05/17/11 Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu 04/28/11 New York
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry 03/10/11 San Francisco
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats 12/14/10 Boston
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine 11/30/10 Detroit
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
Omeros Nabs $25M from Paul Allen and the State, Immune Design Strikes 1st Big Deal, & More Seattle-Area Life Sciences News 10/28/10 Seattle
Immune Design Snags $212M Deal With MedImmune To Provide Vaccine Booster 10/26/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Of Genzyme, Sanofi-Aventis, Biotech Buyout Gossip, and Angry Patients 08/05/10 Boston
Biogen Names CEO, Glaser Leaves Partners, SV Closes $523M Fund, & More Boston-Area Life Sciences News 07/02/10 Boston
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build Pipeline 06/28/10 Boston
Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone 12/09/09 Boston
Epizyme Tacks On Extra $8M Financing For Drugs that Turn Genes On or Off 12/08/09 Boston
Genocea, Attracting Merck and Wyeth Vaccine Gurus, Pushes New Immunizations to Clinic 08/26/09 Boston
Page 1 of 2 next page »